
Clinical
Sirtex reports 100% local tumor control in HCC trial
The DOORwaY90 study reported a 90% complete response rate and 99% best overall response rate for SIR-Spheres Y-90 resin microspheres.
Company

The DOORwaY90 study reported a 90% complete response rate and 99% best overall response rate for SIR-Spheres Y-90 resin microspheres.